Cargando…
Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369008/ https://www.ncbi.nlm.nih.gov/pubmed/32711296 http://dx.doi.org/10.1016/j.msard.2020.102414 |
_version_ | 1783560705002176512 |
---|---|
author | Mallucci, Giulia Zito, Antonio Fabbro, Beatrice Dal Bergamaschi, Roberto |
author_facet | Mallucci, Giulia Zito, Antonio Fabbro, Beatrice Dal Bergamaschi, Roberto |
author_sort | Mallucci, Giulia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7369008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73690082020-07-20 Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod Mallucci, Giulia Zito, Antonio Fabbro, Beatrice Dal Bergamaschi, Roberto Mult Scler Relat Disord Correspondence Elsevier B.V. 2020-10 2020-07-19 /pmc/articles/PMC7369008/ /pubmed/32711296 http://dx.doi.org/10.1016/j.msard.2020.102414 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Mallucci, Giulia Zito, Antonio Fabbro, Beatrice Dal Bergamaschi, Roberto Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title | Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title_full | Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title_fullStr | Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title_full_unstemmed | Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title_short | Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod |
title_sort | asymptomatic sars-cov-2 infection in two patients with multiple sclerosis treated with fingolimod |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369008/ https://www.ncbi.nlm.nih.gov/pubmed/32711296 http://dx.doi.org/10.1016/j.msard.2020.102414 |
work_keys_str_mv | AT malluccigiulia asymptomaticsarscov2infectionintwopatientswithmultiplesclerosistreatedwithfingolimod AT zitoantonio asymptomaticsarscov2infectionintwopatientswithmultiplesclerosistreatedwithfingolimod AT fabbrobeatricedal asymptomaticsarscov2infectionintwopatientswithmultiplesclerosistreatedwithfingolimod AT bergamaschiroberto asymptomaticsarscov2infectionintwopatientswithmultiplesclerosistreatedwithfingolimod |